CHOP researchers advance stem cell studies in a childhood leukemia and diamond blackfan anemia First produced only in the past decade, human induced pluripotent stem cells (iPSCs) are capable of developing into many or even all human cell types. In new research, scientists reprogrammed skin cells from patients with rare blood disorders into iPSCs, highlighting the great promise of these cells in advancing understanding of those challenging diseases - and eventually in treating them. "The technology for generating these cells has been moving very quickly," said hematologist Mitchell J...
More...
More...